Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimu Gong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
JCO Oncology Practice|June 26, 2020
Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical ReviewZimu Gong, Yinghong Wang
Current Oncology Reports|July 2, 2024
Current Status on Management of Primary Plasma Cell LeukemiaZimu Gong, Meera Khosla, Sreeraj Vasudevan, et al.
World Journal of Gastrointestinal Surgery|October 2, 2019
Comparison of treatment modalities in pancreatic pseudocyst: A population based studyYanting Wang, Yazan Abu Omar, Rohit Agrawal, et al.
Coronary Artery Disease|October 19, 2013
Stent implantation in patients with metal allergy: a systemic review and meta-analysisZimu Gong, Min Li, Xiang Guo, et al.
BMC Urology|September 7, 2017
Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literatureXiaotian Wang, Zimu Gong, Shawn Xiang Li, et al.
Cancer Innovation|December 13, 2023
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejectionSong Xue, Lili Miao, Zimu Gong, et al.
American Journal of Clinical Oncology|November 26, 2019
A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate CancerSalman Syed, Spyridon P Basourakos, Faisal S Ali, et al.
Leukemia Research|October 18, 2025
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysisYuanli Lei, Zhiting Tang, Jessica A Reese, et al.
Journal for Immunotherapy of Cancer|December 7, 2018
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center studyHamzah Abu-Sbeih, Faisal S Ali, Dana Alsaadi, et al.
Critical Reviews in Oncology/Hematology|November 28, 2021
Factor Xa inhibitors versus low molecular weight heparin for the treatment of cancer associated venous thromboembolism; A meta-analysis of randomized controlled trials and non-randomized studiesMaryam R Hussain, Faisal S Ali, Dhiran Verghese, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
JCO Oncology Practice|June 26, 2020
Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical ReviewZimu Gong, Yinghong Wang
Current Oncology Reports|July 2, 2024
Current Status on Management of Primary Plasma Cell LeukemiaZimu Gong, Meera Khosla, Sreeraj Vasudevan, et al.
World Journal of Gastrointestinal Surgery|October 2, 2019
Comparison of treatment modalities in pancreatic pseudocyst: A population based studyYanting Wang, Yazan Abu Omar, Rohit Agrawal, et al.
Coronary Artery Disease|October 19, 2013
Stent implantation in patients with metal allergy: a systemic review and meta-analysisZimu Gong, Min Li, Xiang Guo, et al.
BMC Urology|September 7, 2017
Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literatureXiaotian Wang, Zimu Gong, Shawn Xiang Li, et al.
Cancer Innovation|December 13, 2023
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejectionSong Xue, Lili Miao, Zimu Gong, et al.
American Journal of Clinical Oncology|November 26, 2019
A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate CancerSalman Syed, Spyridon P Basourakos, Faisal S Ali, et al.
Leukemia Research|October 18, 2025
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysisYuanli Lei, Zhiting Tang, Jessica A Reese, et al.
Journal for Immunotherapy of Cancer|December 7, 2018
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center studyHamzah Abu-Sbeih, Faisal S Ali, Dana Alsaadi, et al.
Critical Reviews in Oncology/Hematology|November 28, 2021
Factor Xa inhibitors versus low molecular weight heparin for the treatment of cancer associated venous thromboembolism; A meta-analysis of randomized controlled trials and non-randomized studiesMaryam R Hussain, Faisal S Ali, Dhiran Verghese, et al.
Pageof 2